Professional Acne Medication Market is Expected to Reach USD 5.24 Billion by 2030

The impact of unhealthy food habits and sedentary lifestyles on the skin along with the increasing cases of acne vulgaris condition in teenagers & adults are driving the growth of the professional acne medication industry.

According to a new research report by Next Move Strategy Consulting, the global professional acne medication market size was valued at USD 3.22 billion in 2023, and is expected to reach USD 5.24 billion by 2030, with a CAGR of 7.2% during the forecast period, 2024–2030.

Unhealthy food habits and sedentary lifestyles significantly drive the growth of the professional acne medication market. As people increasingly consume diets rich in processed foods, high in sugar, and laden with unhealthy fats, it can lead to hormonal imbalances and increased inflammation within the body. These dietary choices can intensify acne and skin issues. In 2020, a survey carried out by Harvard Medical School found a link between consuming a lot of high-fat and high-sugar foods and an increased likelihood of having acne. The research included 24,000 participants, and results showed that individuals who had acne during the survey were 76% more likely to report consuming a substantial amount of greasy and sugary foods on the day before the survey.

Additionally, sedentary lifestyles characterized by limited physical activity contribute to poor circulation and impaired metabolic processes, potentially worsening skin conditions. These unhealthy food habits and sedentary lifestyles contribute to the persistence and exacerbation of acne conditions, prompting people to seek professional acne medication to manage their skin issues.

Moreover, the growing prevalence of acne vulgaris in teenagers and adults has become a driving force behind the expansion of the professional acne medication market. Based on a survey by Yale Medicine, approximately half of women in their 20s, one-third of women in their 30s, and one-fourth of women in their 40s experience acne vulgaris. Lifestyle factors such as elevated stress levels, unhealthy dietary choices, and disrupted sleep patterns play a role in exacerbating acne, while environmental factors such as pollution can worsen the condition. Additionally, hormonal imbalances during puberty in teenagers and various life stages in adults contribute to acne breakouts. Rising awareness of the psychological and physical impacts of acne coupled with the influence of social media on self-image motivated more individuals to seek professional dermatological solutions.

Furthermore, the declining state of the environment, which includes being exposed to polluted air, can make skin problems worse and exacerbate acne. This environmental impact will boost the market as individuals seek effective solutions.

However, the emergence of over-the-counter (OTC) alternatives has emerged as a significant hindrance to the growth of the professional acne medication market. These alternatives, such as at-home light therapy devices and advanced skincare products, provide users with cost-effective and user-friendly options to tackle acne without needing a prescription or professional assistance.

On the other hand, ongoing research and developments in dermatology are leading to the creation of more effective and innovative professional acne treatments. These advancements are expected to attract a broader range of patients seeking advanced solutions. It also holds the promise of enhancing the effectiveness of acne treatments. Furthermore, it expands the appeal of such treatments to a wider spectrum of patients searching for advanced solutions to combat this common skin condition.

Request a sample here: https://www.nextmsc.com/professional-acne-medication-market/request-sample

According to the report, leading players operating in the professional acne medication market include Almirall SA, Bausch Health Companies, Inc., GlaxoSmithKline Plc (GSK), Galderma SA, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, STRATA Skin Sciences, Inc., Mayne Pharma Group Limited, and Pfizer, Inc., and others. 

Key Insights from the Professional Acne Medication Market Report:

• The information related to key drivers, restraints, and opportunities and their impact on the professional acne medication market is provided in the report.

• The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.

• The market share of the players in the global professional acne medication market along with their competitive analysis are provided in the report.

Share this post?